
Sign up to save your podcasts
Or


Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).
By Cleveland Clinic Center for Continuing Education5
77 ratings
Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).

5,016 Listeners

292 Listeners

3,331 Listeners

1,154 Listeners

3,526 Listeners

9,248 Listeners

8,947 Listeners

196 Listeners

521 Listeners

29,191 Listeners

229 Listeners

1,657 Listeners

391 Listeners

230 Listeners

26 Listeners